Evidence map›Paper›PMID 41211348›Full record

ArticleJAAD case reports2025

Diffuse cutaneous ALK-immunoreactive histiocytosis with

Sanjana Likki, Kevin Lee, Fiorinda Muhaj, Wei Wang, Pei Lin, Woo Cheal Cho, Doina Ivan, Carlos A Torres-Cabala, Luis Fayad, Jonathan L Curry

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sanjana LikkiUniversity of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas.
Kevin LeeDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fiorinda MuhajDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wei WangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pei LinDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Woo Cheal ChoDepartment of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Doina IvanDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Carlos A Torres-CabalaDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Luis FayadDepartment of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Jonathan L CurryDepartment of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alectinibALK-immunoreactiveALK-positiveanaplastic lymphoma kinasecrizotinibhistiocytic

Identifiers

PMID41211348
PMCPMC12595125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.